Onderneming Briacell Therapeutics Corp Toronto S.E.
Aandelen
CA10778Y1043
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 01-11-16 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 01-02-16 |
Chief Tech/Sci/R&D Officer | 53 | 01-05-21 | |
Chief Tech/Sci/R&D Officer | 62 | 16-02-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 10-05-16 |
Marc Lustig
BRD | Director/Board Member | 51 | 31-08-21 |
Rebecca Taub
BRD | Director/Board Member | 71 | 07-03-18 |
Director/Board Member | 66 | 18-03-19 | |
William Williams
CEO | Chief Executive Officer | 68 | 01-11-16 |
Jane Gross
BRD | Director/Board Member | 67 | 01-11-21 |
Chairman | 39 | 04-02-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 18 284 661 | 15 440 125 ( 84,44 %) | 0 | 84,44 % |
Bedrijfsgegevens
BriaCell Therapeutics Corp.
Bellevue Centre 235 -15th Street
V7T 2X1, West Vancouver
+604 921 1810
http://www.briacell.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,21% | 122 mld. | |
+21,93% | 116 mld. | |
+22,18% | 27,03 mld. | |
-21,48% | 20,36 mld. | |
-16,89% | 16,43 mld. | |
-18,59% | 15,91 mld. | |
-44,74% | 15,6 mld. | |
+62,61% | 14,94 mld. | |
+3,04% | 13,59 mld. |